Latest Health News

Mayfield Childcare reported FY25 revenue growth driven by acquisitions but faced EBITDA decline due to occupancy and integration issues. Embark Education’s takeover bid adds a new dimension to the company’s strategic outlook.

Oldfields Holdings Limited remains suspended from ASX trading following its failure to lodge critical half-year financial reports after announcing a capital raising.

Variscan Mines has announced a delay in its earn-in agreement for Irish zinc assets after vendors failed to meet financial obligations within the agreed timeframe. The company’s board will now reassess next steps amid growing uncertainty.

Cosmos Exploration Limited has voluntarily suspended its shares from ASX trading as it prepares to announce significant developments involving an Option Agreement and a capital Placement.

Opthea Limited reports a striking turnaround with a $339.9 million profit for H1 2026, driven by a strategic refocus on developing OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women. The company plans a rebrand and ASX reinstatement as it charts a new course in rare respiratory health.

Vmoto Limited reported an 18% revenue decline to $46.8 million and a $9.9 million net loss in FY25, while accelerating its transformation into a full-stack electric mobility solutions provider with new global partnerships and product innovations.

Pointerra Limited reported a $2.14 million loss for the half-year ending December 2025 amid a 51% revenue decline, yet the company highlights promising contract wins and a growing recurring revenue base that could drive a turnaround in the second half.

I Synergy Group Limited reported a 15.63% drop in revenue to AUD 0.81 million for FY2025, alongside a 21.5% increase in net loss to AUD 0.34 million, with auditors flagging going concern uncertainties.

CONNEQT Health reported a 40% revenue increase to $2.28 million for the half-year ending December 2025, driven by strong sales of its CONNEQT Pulse device and early subscription uptake. Despite narrowing its net loss by 14%, the company continues to navigate operational restructuring and funding challenges as it pivots towards a recurring revenue model.

PainChek Limited reported a half-year loss of AUD 4.7 million but achieved a major regulatory milestone with FDA clearance for its Adult App, unlocking significant US market opportunities. The company also completed a share consolidation and raised capital to support growth.

Verbrec Limited has reported a remarkable turnaround in its half-year results, posting a $9 million net profit and announcing its first interim dividend in the current period. Strategic acquisitions and a sharp rise in net tangible assets underpin this strong performance.

ECS Botanics has reported a return to profitability and positive cash flow in the first half of FY26, driven by a strategic shift to branded products and major infrastructure expansion.